Aandelen in “Biotechnologie”
Aandeel | Datum | Koers | Evolutie |
---|---|---|---|
Pacific Biosciences of California Inc | 2/12 | 1,930 USD
+1,05% |
+1,05% |
Palatin Technologies Inc. | 2/12 | 1,150 USD
+0,88% |
+0,88% |
Passage Bio Inc | 2/12 | 1,010 USD
-10,62% |
-10,62% |
PDS Biotechnology Corporation | 2/12 | 2,150 USD
-1,83% |
-1,83% |
Personalis Inc | 2/12 | 3,900 USD
-1,76% |
-1,76% |
Perspective Therapeutics Inc | 2/12 | 4,150 USD
-4,60% |
-4,60% |
Pharming Group N.V. | 2/12 | 7,550 USD
+2,72% |
+2,72% |
Pharming Group N.V. | 17:35 | 0,699 EUR
-3,45% |
-3,45% |
Phio Pharmaceuticals Corp | 2/12 | 2,920 USD
+7,35% |
+7,35% |
Pieris Pharmaceuticals Inc | 2/12 | 16,430 USD
+1,08% |
+1,08% |
Plant Advanced Technologies Pat | 29/11 | 12,500 EUR
0,00% |
0,00% |
Pliant Therapeutics Inc | 2/12 | 15,510 USD
+12,39% |
+12,39% |
Plus Therapeutics Inc | 2/12 | 1,290 USD
+0,78% |
+0,78% |
Poseida Therapeutics Inc | 2/12 | 9,320 USD
+0,11% |
+0,11% |
Poxel | 2/12 | 0,198 EUR
+1,54% |
+1,54% |
Precigen Inc | 2/12 | 0,909 USD
-2,49% |
-2,49% |
Precipio Inc | 2/12 | 5,960 USD
+0,30% |
+0,30% |
Precision Biosciences Inc | 2/12 | 6,870 USD
-5,76% |
-5,76% |
Prelude Therapeutics Inc | 2/12 | 1,050 USD
0,00% |
0,00% |
ProMIS Neurosciences Inc. | 2/12 | 0,912 USD
-2,94% |
-2,94% |
ProQR Therapeutics N.V | 2/12 | 3,730 USD
-2,86% |
-2,86% |
Protagonist Therapeutics Inc | 2/12 | 43,260 USD
-1,23% |
-1,23% |
Protara Therapeutics Inc | 2/12 | 2,530 USD
-15,95% |
-15,95% |
Prothena Corporation plc | 2/12 | 15,000 USD
-7,46% |
-7,46% |
PTC Therapeutics Inc | 2/12 | 52,070 USD
+18,66% |
+18,66% |
Pulmatrix Inc | 2/12 | 6,340 USD
-4,52% |
-4,52% |
Puma Biotechnology Inc | 2/12 | 3,200 USD
-5,60% |
-5,60% |
PureTech Health Plc | 2/12 | 167,400 GBX
+0,36% |
+0,36% |
PureTech Health Plc | 2/12 | 21,990 USD
-0,99% |
-0,99% |